https://doctransparency.com/doctor/fl/west-palm-beach/sheldon-regenbaum-1134126014
Medicare Enrolled

Dr. Sheldon Regenbaum, MD

Pain Medicine · West Palm Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1500 N DIXIE HWY, West Palm Beach, FL 33401
5618338893
In practice since 2005 (20 years)
NPI: 1134126014 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Regenbaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Regenbaum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Regenbaum

Dr. Sheldon Regenbaum is a pain medicine in West Palm Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Regenbaum performed 1,945 Medicare services across 1,071 unique beneficiaries.

Between the years covered by Open Payments, Dr. Regenbaum received a total of $8,205 from 27 pharmaceutical and/or device companies across 156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Regenbaum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 1,945 Medicare services$ $8,205 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,945
Medicare services
Bottom 47% in FL for pain medicine
1,071
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~97 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)691$94$635
Steroid injection (triamcinolone)265$1$7
Office visit, established patient (20-29 min)213$66$432
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes107$10$267
Testing for presence of drug, read by direct observation105$12$313
Injection of substance into lower spine canal using imaging guidance79$79$1,473
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level64$97$1,623
New patient office visit (45-59 min)59$131$988
Insertion of spinal neurostimulator electrode array through skin44$260$7,934
Injection of lower or sacral spine facet joint using imaging guidance, single level40$99$1,413
Injection of lower or sacral spine facet joint using imaging guidance, second level40$57$706
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level36$42$762
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint31$67$1,381
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint30$209$3,350
New patient office visit (30-44 min)30$91$643
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms26$195$631
Aspiration and/or injection of fluid large joint using ultrasound guidance22$83$571
Injection of substance into middle or upper spine canal using imaging guidance20$88$1,657
Ultrasonic guidance for needle placement16$43$1,083
Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin14$806$9,477
Insertion of spinal neurostimulator generator or receiver13$168$2,360
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$8,205
Total received (2018-2023)
Avg $1,368/year across 6 years
Top 21% in FL for pain medicine
27
Companies
156
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,205 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$3,530
2022
$1,844
2021
$1,206
2020
$235
2019
$449
2018
$940

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Nalu Medical, Inc.
$1,675
Medtronic, Inc.
$1,384
BOSTON SCIENTIFIC CORPORATION
$1,165
Spinal Simplicity, LLC
$1,161
Abbott Laboratories
$756
Nevro Corp.
$430
Vertos Medical, Inc.
$333
Collegium Pharmaceutical, Inc.
$263
PFIZER INC.
$232
Allergan Inc.
$127
Boston Scientific Corporation
$111
BioDelivery Sciences International, Inc.
$89
Allergan, Inc.
$89
Assertio Therapeutics, Inc.
$85
Relievant Medsystems, Inc.
$52
AstraZeneca Pharmaceuticals LP
$49
Sentynl Therapeutics, Inc.
$28
Scilex Pharmaceuticals Inc.
$23
Nuvectra Corporation
$23
Valinor Pharma, LLC
$23
Daiichi Sankyo Inc.
$20
Stimwave Technologies Incorporated
$19
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$15
Vertiflex, Inc.
$15
Egalet US Inc
$14
Shionogi Inc
$13
Purdue Pharma L.P.
$11
Top 3 companies account for 51.5% of total payments
Associated products mentioned in payments ›
Algovita · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · DRG Accessories · DRG IPGs · General - Pain Management · Gralise · HA MINUTEMAN G3-R · INTELLIS ADAPTIVESTIM · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · LYRICA · Levorphanol Tartrate · MOVANTIK · Morphabond ER · Nalu Neurostimulation System · Omnia · PROCLAIM · PRODIGY · Penta SCS Leads · Proclaim Family of SCS IPGs · S-Series SCS Leads · SPECTRA WAVEWRITER · SPRIX · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · Symproic · TYRX · UBRELVY · VANTA ADAPTIVESTIM · XTAMPZA · XTAMPZAER · Xtampza ER · XtampzaER · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $422 per 100 Medicare services performed
Looking for a pain medicine in West Palm Beach?
Compare pain medicines in the West Palm Beach area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain Medicines within 10 mi
6
Per 100K population
0.4
County median income
$81,115
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Regenbaum is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Regenbaum experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Regenbaum performed 691 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Regenbaum receive payments from pharmaceutical companies?
Yes. Dr. Regenbaum received a total of $8,205 from 27 companies across 156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Regenbaum's costs compare to other pain medicines in West Palm Beach?
Dr. Regenbaum's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Regenbaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →